CSF1 - colony stimulating factor 1 Gene
Species: Bos taurus
Gene Type: protein coding
Gene ID: 281094
CSF1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_174026.1 | NP_776451.1 | macrophage colony-stimulating factor 1 precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
macrophage colony-stimulating factor 1 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-16749 | Pexidartinib | 99.64% | Yes | |
| HY-16749A | Pexidartinib hydrochloride | 99.82% | Yes | |
| HY-12297 | Sulfatinib | Inhibitor | 99.52% | Unkown |
Clinical Phase
Bioactive Molecules
(18)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-50905 | Dovitinib | Inhibitor | 99.88% | Phase 3 |
| HY-153920 | Pimicotinib | Inhibitor | 99.92% | Phase 3 |
| HY-145601 | Tinengotinib | Inhibitor | 99.57% | Phase 3 |
| HY-124526 | Chiauranib | Inhibitor | 98.97% | Phase 3 |
| HY-D3284 | CSF1 | / | Phase 3 | |
| HY-12768A | Sotuletinib hydrochloride | Inhibitor | 99.43% | Phase 2 |
| HY-109190 | Seralutinib | Inhibitor | 99.94% | Phase 2 |
| HY-109086 | Edicotinib | Inhibitor | 99.68% | Phase 2 |
| HY-19772 | GSK3117391 | Inhibitor | 99.40% | Phase 2 |
| HY-136362 | ARRY-382 | Inhibitor | 99.95% | Phase 2 |
| HY-152830A | Adrixetinib TFA | 99.82% | Phase 2 | |
| HY-12768B | Sotuletinib dihydrochloride | Inhibitor | / | Phase 2 |
| HY-109086A | Edicotinib hydrochloride | Inhibitor | / | Phase 2 |
| HY-114153 | PLX5622 | Inhibitor | 99.95% | Phase 1 |
| HY-114153A | PLX5622 hemifumarate | Inhibitor | 99.93% | Phase 1 |
| HY-111787 | Elzovantinib | Inhibitor | 99.93% | Phase 1 |
| HY-101768 | PRN1371 | Inhibitor | 99.78% | Phase 1 |
| HY-10204 | OSI-930 | 98.33% | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99245 | Emactuzumab | Inhibitor | 97.60% | Phase 3 |
| HY-P990043 | Iluzanebart | 98.63% | Phase 2 | |
| HY-P99452 | Axatilimab | Inhibitor | 99.59% | Phase 2 |
| HY-P99259 | Cabiralizumab | Inhibitor | 99.73% | Phase 2 |
| HY-P99368 | Lacnotuzumab | Inhibitor | 99.9% | Phase 2 |
| HY-P991048 | AMG-820 | Inhibitor | 98% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(68)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-12768 | Sotuletinib | Inhibitor | 99.97% | Unkown |
| HY-132166 | Velzatinib | Inhibitor | 99.40% | Unkown |
| HY-10408 | Ki20227 | Inhibitor | 99.51% | Unkown |
| HY-159838 | Enrupatinib | Inhibitor | 98.90% | Unkown |
| HY-161025 | SYHA1813 | Inhibitor | 99.46% | Unkown |
| HY-101774 | CSF1R-IN-1 | Inhibitor | 98.04% | Unkown |
| HY-159108 | AZ683 | Inhibitor | 98.57% | Unkown |
| HY-117244 | AZD7507 | Inhibitor | 99.57% | Unkown |
| HY-147615 | CSF1R-IN-12 | 98.75% | Unkown | |
| HY-122906 | JTE-952 | Inhibitor | 99.86% | Unkown |
| HY-152830 | Adrixetinib | 99.55% | Unkown | |
| HY-126297 | c-Fms-IN-10 | Inhibitor | 98.63% | Unkown |
| HY-139990 | CSF1R-IN-3 | Inhibitor | 98.10% | Unkown |
| HY-145809 | FASN-IN-5 | Inhibitor | 99.98% | Unkown |
| HY-112451 | cFMS Receptor Inhibitor II | Inhibitor | 99.88% | Unkown |
| HY-132935 | BPR1R024 | Inhibitor | 98.50% | Unkown |
| HY-160842 | CSF1R-IN-24 | Inhibitor | 98.10% | Unkown |
| HY-117273 | AZ304 | Inhibitor | 99.77% | Unkown |
| HY-119942 | c-Fms-IN-8 | Inhibitor | 99.50% | Unkown |
| HY-101526 | GENZ-882706 | Inhibitor | / | Unkown |
| HY-13075 | c-Fms-IN-3 | Inhibitor | 99.69% | Unkown |
| HY-132935A | BPR1R024 mesylate | Inhibitor | / | Unkown |
| HY-RS03228 | CSF1R Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-13493 | AC710 | Inhibitor | 99.13% | Unkown |
| HY-13496 | JNJ-28312141 | Inhibitor | / | Unkown |
| HY-RS16853 | Csf1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-101034 | CHMFL-ABL/KIT-155 | / | Unkown | |
| HY-174366 | JMC14 | Inhibitor | / | Unkown |
| HY-10109A | AS-605240 potassium | Inhibitor | / | Unkown |
| HY-112446 | ST638 | Inhibitor | / | Unkown |
| HY-13496A | JNJ-28312141 hydrochloride | Inhibitor | / | Unkown |
| HY-144040 | CSF1R-IN-4 | / | Unkown | |
| HY-144041 | CSF1R-IN-5 | Inhibitor | / | Unkown |
| HY-144042 | CSF1R-IN-6 | / | Unkown | |
| HY-147608 | CSF1R-IN-7 | Inhibitor | / | Unkown |
| HY-147609 | CSF1R-IN-8 | Inhibitor | / | Unkown |
| HY-147610 | CSF1R-IN-9 | Inhibitor | / | Unkown |
| HY-147611 | CSF1R-IN-10 | Inhibitor | / | Unkown |
| HY-147616 | CSF1R-IN-13 | / | Unkown | |
| HY-147617 | CSF1R-IN-14 | / | Unkown | |
| HY-153012 | Axl/Mer/CSF1R-IN-1 | Inhibitor | / | Unkown |
| HY-153243 | IACS-9439 | Inhibitor | / | Unkown |
| HY-153277 | Axl/Mer/CSF1R-IN-2 | Inhibitor | / | Unkown |
| HY-153920A | Pimicotinib hydrochloride | Inhibitor | / | Unkown |
| HY-155001 | CSF1R-IN-15 | Inhibitor | / | Unkown |
| HY-155550 | CSF1R-IN-17 | Antagonist | / | Unkown |
| HY-157422 | CSF1R-IN-19 | Inhibitor | / | Unkown |
| HY-157996 | CSF1R-IN-21 | Inhibitor | / | Unkown |
| HY-158050 | PXB17 | Inhibitor | / | Unkown |
| HY-158148 | CSF1R-IN-23 | Inhibitor | / | Unkown |
| HY-158363 | CSF1R-IN-25 | Inhibitor | / | Unkown |
| HY-161084 | CSF1R-IN-18 | Inhibitor | / | Unkown |
| HY-162309 | CSF1R-IN-20 | Inhibitor | / | Unkown |
| HY-162415 | CSF1R-IN-22 | / | Unkown | |
| HY-168954 | CSF1R-IN-26 | / | Unkown | |
| HY-176194 | Antifibrotic agent 1 | / | Unkown | |
| HY-183569 | CSF1R-IN-27 | Inhibitor | / | Unkown |
| HY-183931 | NPA101.3 | Inhibitor | / | Unkown |
| HY-D3217 | Ctrl-CSF1 | / | Unkown | |
| HY-RS03227 | CSF1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS03229 | Csf1r Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS03230 | Csf1r Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-13493A | AC710 Mesylate | Inhibitor | / | Unkown |
| HY-159503A | Segigratinib hydrochloride | Inhibitor | / | Unkown |
| HY-164529 | SJ-C1044 | Inhibitor | 98.63% | Unkown |
| HY-174606 | Human IL34 mRNA | / | Unkown | |
| HY-174734 | Human CSF1 mRNA | / | Unkown | |
| HY-RS23294 | Csf1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990125 | Anti-Mouse CSF1R/CD115 Antibody (AFS98) | 99.38% | Unkown | |
| HY-P990257 | Anti-Mouse CSF1 Antibody (5A1) | Inhibitor | 96.799% | Unkown |
| HY-P990849 | Anti-CSF1R/CD115 Antibody (2-4A5-4) | Inhibitor | / | Unkown |
| HY-P991313 | PD-360324 | Inhibitor | / | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Homo sapiens | CSF1 | NCBI | NCBI:1435 |
| Canis familiaris | CSF1 | NCBI | NCBI:611795 |
| Macaca fascicularis | CSF1 | NCBI | NCBI:102141631 |
| Mus musculus | CSF1 | NCBI | NCBI:12977 |
| Rattus norvegicus | CSF1 | NCBI | NCBI:78965 |
| Macaca mulatta | CSF1 | NCBI | NCBI:702532 |